Steward Partners Investment Advisory
VNDA icon

Steward Partners Investment Advisory’s Vanda Pharmaceuticals VNDA Stock Holding History

Steward Partners Investment Advisory’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.9K Buy
2,435
+2,066
+560% +$13.5K ﹤0.01% 3534
2026
Q1 		$2.55K Buy
+369
New +$2.85K ﹤0.01% 3985
2020
Q1 		– Sell
-1
Closed – – 2712
2019
Q4 		$0 Sell
1
-1
-50% -$15 ﹤0.01% 2752
2019
Q3 		$0 Hold
2
– – ﹤0.01% 2777
2019
Q2 		$0 Buy
+2
New +$32 ﹤0.01% 2695

Other funds holding VNDA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Steward Partners Investment Advisory's VNDA Position: Q2 2026 in Review

Steward Partners Investment Advisory increased its Vanda Pharmaceuticals (VNDA) stake by 560% in Q2 2026, buying an estimated $13.5K and bringing the position to 2,435 shares worth $14.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3534.

Steward Partners Investment Advisory first reported a position in VNDA in Q2 2019 and has held it in 5 quarters since. 172 funds tracked by Wall St. Rank hold VNDA as of Q2 2026.

  • Steward Partners Investment Advisory held 2,435 shares of Vanda Pharmaceuticals worth $14.9K as of Q2 2026.
  • Steward Partners Investment Advisory bought 2,066 Vanda Pharmaceuticals shares in Q2 2026, an estimated $13.5K.
  • Vanda Pharmaceuticals made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q2 2026, its #3534 holding.
  • Steward Partners Investment Advisory first reported a position in Vanda Pharmaceuticals in Q2 2019 and has held it in 5 quarters since.
  • 172 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.